Trodelvy dosing is 10 mg/kg IV on days 1 and 8 of 21-day cycles, continued until progression or unacceptable toxicity; pembrolizumab schedules follow prescriber determination. Safety requires ...

New Trump tariffs on pharmaceuticals could double the cost of common prescription drugs, raising prices for medications like ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Padcev® (enfortumab vedotin-ejfv ...

Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...

Japanese drugmaker Astellas Pharma has won European Commission (EC) approval for Padcev (enfortumab vedotin) in combination ...

The approvals are based on data from the pivotal Phase III LITESPARK-022 trial, which enrolled 1,841 patients.

Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw their risk of disease recurrence cut by nearly half over five years, ...

Mixed stock index futures as tech rebounds: watch Micron earnings, Merck’s Keytruda approval, Wendy’s WSB surge, and ...

By Michael Erman June 22 (Reuters) - Pfizer said on Monday that one of the key experimental drugs it picked up in its $43 ...

Keytruda hauled in more than $40 billion in revenue from 2019 through 2021. (Photo by Marko Georgiev/Getty Images) On the second night of the largest annual European cancer conference, some 100 Merck ...